Claim: "MoH says as of today's date, no pharmacy should sell 'Misoprostol,' the main tablet girls can use to do an abortion."
Verdict: Misleading
Full Text: shortly after Liberia's health ministry released a regulatory statement on April 3, a widely followed Facebook blogger known as Yekeh Kolubah Published a post claiming the government had issued an outright and immediate ban on the sale of Misoprostol, commonly marketed as Cytotec, in all pharmacies across Liberia.
The post described the drug as "the main tablet girls can use to do an abortion" and suggested it could no longer be purchased anywhere with immediate effect. the post rapidly spread across Liberian social media, generating 1.9 thousand public reactions, 650 comments and 148 shares, with citizens debating the accuracy of the claim. the mixed public reaction and the serious public health implications of misrepresenting such a directive led to TSM verifying the information.
Misoprostol is a synthetic prostaglandin E1 analog, a lab-made compound that mimics natural hormones found in the body. it was first approved by the U.S. Food and Drug Administration on December 27, 1988, under the brand name Cytotec, originally developed to prevent stomach ulcers caused by non-steroidal anti-inflammatory drugs such as ibuprofen.
Misoprostol is a synthetic prostaglandin E1 analog, a lab-made compound that mimics natural hormones found in the body. it was first approved by the U.S. Food and Drug Administration on December 27, 1988, under the brand name Cytotec, originally developed to prevent stomach ulcers caused by non-steroidal anti-inflammatory drugs such as ibuprofen.
The drug was synthesized as far back as 1973 by researchers at G.D. Searle and Company (later acquired by Pfizer).
Its uses in reproductive health emerged in the 1980s, when women in Latin America noticed that miscarriage was a side effect. since then, it has become an essential medicine recognized by the World Health Organization for treating postpartum hemorrhage, the leading cause of maternal death in sub-Saharan Africa; managing miscarriages safely, including labor; and for use alongside mifepristone in medical abortions. It is included on the World Health Organization's Model List of Essential Medicines. In Liberia, Misoprostol has been widely available in pharmacies with minimal regulation, often sold or as little as $US5 or more per dose depending on the location.
Verification: A review of the Ministry's April 3 official press statement, published on its Facebook page, did not announce a ban on the sale of Misoprostol, instead it established a stricter regulatory framework for how the drug is dispensed.
the ministry's directive actually points out the following:
- Misoprostol must only be sold upon presentation of a valid prescription from a licensed physician or authorized prescriber under Liberian law.
- The drug must be dispensed only under the direct supervision of a licensed pharmacist or an authorized dispensing professional.
- Sales must occur exclusively within appropriately licensed facilities, not informal drug shops or unlicensed outlets.
- The Ministry stated it had "noted, with alarm," the widespread, unregulated sale and usage of the drug across Liberia.
- The government did not cite specific cases of misuse or abuse to justify its concerns.
In plain terms, the ministry tightened the conditions under which pharmacists may dispense misoprostol. it did not ban the drug outright as posted by the blog. Licensed pharmacies can still stock and dispense it, but only to patients presenting a valid doctor's prescription and under professional supervision. this is a restriction on access, not an abolition of availability.
"The Ministry didn't ban the sale of misoprostol tablets in pharmacies. Rather, it warned against the selling of the drug by unauthorized pharmacists." — DUBAWA Fact-Check, April 7, 2026
Also, west African fact-checking organization DUBAWA independently investigated the same claim and reached an identical conclusion, rating the blogger's assertion as Misleading. DUBAWA found that the ministry of health mandated misoprostol be dispensed only under the direct supervision of a licensed pharmacist or authorized dispensing professional working within an appropriately licensed facility. Their review also confirmed the claim had generated over 650 reactions and nearly 200 comments on Facebook at the time of publication, underscoring the scale of the misinformation's reach.
Beyond the claim, the Ministry's directive has sparked significant controversy and public backlash from health advocates, human rights organizations, and ordinary Liberians. the Sexual Reproductive Health and Rights Champions-Liberia, led by Titus B. Pakalah, issued a strong public statement condemning the directive. Pakalah described the new restrictions as a direct violation of Liberia's health policy commitments and a breach of the government's 365 day National Action Plan aimed at reducing maternal deaths.
"We express grave concern over the Ministry of Health's directive tightening access to Misoprostol, particularly in light of the ongoing U.S.–Liberia health compact and the government's own commitments under its 365-Day National Action Plan to address maternal mortality," Pakalah said.
The Women's NGO Secretariat of Liberia, through its executive director, warned that the measures must not inadvertently restrict access to life-saving services. Advocates underscored that misoprostol has served as a critical tool, particularly for rural women, low-income communities, and survivors of sexual violence who lack consistent access to formal healthcare.
"Does a young girl in Henry's Town, Gbarpolu County, have access to a licensed pharmacist?" Amelia Siaffa, acting executive director of Sister Aid Liberia, said.
The directive arrives against a charged backdrop. under current Liberian law, illegal abortion is punishable by up to five years in prison, even though there's no report of someone serving such a term for violation.
Currently, the country is simultaneously monitoring a pivotal bill in the Liberian Senate, the New Public Health bill, passed by the House of Representatives in 2022, which contains a provision that would legalize abortion up to 14 weeks of pregnancy if performed by a doctor. Already, 38,000 abortions have taken place between September 2021 and March 2022, according to a fact sheet published by Liberia's ministry of Health and Africa Population and Health Research sponsored by Clinton Health Access Initiatives-Liberia.
Nationally, 11 percent of those abortions were near misses or resulted in death. Liberia's maternal mortality ratio stood at 628 per 100,000 live births in 2023, still among the highest in the region, though improved from 1,749 per 100,000 in 2000. And 1 in 3 girls between ages 15 and 19 is either a mother or pregnant, and rural healthcare access remains severely limited.
Currently, the country is simultaneously monitoring a pivotal bill in the Liberian Senate, the New Public Health bill, passed by the House of Representatives in 2022, which contains a provision that would legalize abortion up to 14 weeks of pregnancy if performed by a doctor. Already, 38,000 abortions have taken place between September 2021 and March 2022, according to a fact sheet published by Liberia's ministry of Health and Africa Population and Health Research sponsored by Clinton Health Access Initiatives-Liberia.
Nationally, 11 percent of those abortions were near misses or resulted in death. Liberia's maternal mortality ratio stood at 628 per 100,000 live births in 2023, still among the highest in the region, though improved from 1,749 per 100,000 in 2000. And 1 in 3 girls between ages 15 and 19 is either a mother or pregnant, and rural healthcare access remains severely limited.
Conclusion: The claim that the Liberia Ministry of Health banned the sale of misoprostol in all pharmacies with immediate effect is misleading. The Ministry's April 3, 2026 press release did not ban the drug.
It imposed stricter dispensing conditions, requiring a valid prescription from a licensed physician and supervision by a licensed pharmacist within a licensed facility. Misoprostol remains legally obtainable through proper medical channels. The viral claim conflated a regulatory restriction with an outright prohibition, a distortion with real potential to mislead the public about their healthcare options. This finding is corroborated by an independent fact-check from DUBAWA, which reached the same conclusion.
It imposed stricter dispensing conditions, requiring a valid prescription from a licensed physician and supervision by a licensed pharmacist within a licensed facility. Misoprostol remains legally obtainable through proper medical channels. The viral claim conflated a regulatory restriction with an outright prohibition, a distortion with real potential to mislead the public about their healthcare options. This finding is corroborated by an independent fact-check from DUBAWA, which reached the same conclusion.
